Announcement on Convening the 2025 Semi-annual Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening the 2025 Semi-annual Performance Briefing
Filed with SSE · · 2 pages · Chinese
Release
Shenzhen YHLO Biotech Co. Ltd. on 6ix
Earlier from Shenzhen YHLO Biotech
- Announcement on Voluntary Disclosure of Receipt of Notification for Grant of Invention Patent Rights
- Announcement on Voluntary Disclosure of Obtaining IVDR CE Certificate
- Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2025
- Announcement on Shareholding Reduction Plan of the Controlling Shareholder, Actual Controller and Chairman, and Partial Senior Executives and Key Technical Personnel
- Announcement on Implementation of Dividend Distribution for 2024
Later from Shenzhen YHLO Biotech
- Announcement on the Achievements of Vesting Conditions in the 2nd Vesting Period of the 2023 Restricted Stock Incentive Plan
- Announcement on Selection of the Manufacturing Industry Single Crown Enterprises
- 关于控股股东、实际控制人兼董事长及其一致行动人权益变动触及1%整数倍的提示性公告
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Vesting Results in the 2nd Vesting Period of the 2023 Restricted Stock Incentive Plan (1st Batch) and Shares Listing
Follow Shenzhen YHLO Biotech into a list and get an email when it puts out news.
Follow Shenzhen YHLO Biotech